MBQ Pharma

MBQ PharmaMBQ Pharma
MBQ Pharma

MBQ Pharma

MBQ Pharma is a biopharmaceutical company developing precision-targeted therapies for cancer, autoimmunity, and fibrosis by inhibiting GTPases.

2018ActiveSan Juan, Puerto Rico
Rate

About

MBQ Pharma is a biopharmaceutical startup focused on developing first-in-class therapeutics that precisely target GTPases, which are critical cell regulators in the pathogenesis of cancer, metastasis, autoimmune, and fibrotic chronic degenerative diseases. Their lead compound, MBQ-167, is a dual inhibitor of Rac and CDC42, designed to remove pre-existing metastases and is currently in Phase 1 clinical trials for advanced breast cancer.
Frequently asked

What does MBQ Pharma do?

MBQ Pharma is a biopharmaceutical startup focused on developing first-in-class therapeutics that precisely target GTPases, which are critical cell regulators in the pathogenesis of cancer, metastasis, autoimmune, and fibrotic chronic degenerative diseases. Their lead compound, MBQ-167, is a dual inhibitor of Rac and CDC42, designed to remove pre-existing metastases and is currently in Phase 1 clinical trials for advanced breast cancer.

Is MBQ Pharma trustworthy and reputable?

StartupHub's Data Trust & Reputation score for MBQ Pharma is 60 out of 100, based on site security posture and privacy practices.

Where is MBQ Pharma headquartered?

MBQ Pharma is headquartered in San Juan, Puerto Rico.

When was MBQ Pharma founded?

MBQ Pharma was founded in 2018.

What industry does MBQ Pharma operate in?

MBQ Pharma operates in Biotech, MedTech, Drug Discovery, Oncology, Autoimmunity, Fibrosis.

Comments

No comments yet. Be the first to share your take.